BLTE · Belite Bio Inc ADR
United States · RS rating 54 · As of 2026-11-03
| Price | 152.17 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 46 / 58 / 82 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 42 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -7.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +21.4% |
| Market cap (USD) | $6.6B |